Promising treatments for some of the world’s most neglected but high-burden diseases may already exist — sitting on pharmacy shelves around the world, manufactured at scale, and costing a fraction of new medicines. They just haven’t been tested for the right indication yet.
The aim of this RFP is to provide grants for clinical repurposing trials aimed at benefitting patients from low- and lower-middle-income countries (LMICs) as defined by the World Bank.
The available budget for this call is up to $20 million USD, depending on the quality of proposals. We expect to fund multiple proposals under this call, but there is no maximum size for individual proposals. If we receive more high-quality proposals than our budget can support, we will seek co-funding from partners.
